ArticleFrontiers in immunology2022

Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma.

Lei Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.